RxDoctor Payments Data

Elliott Campbell, MD

MOHS-Micrographic Surgery · Rochester, MNNPI 1265994412

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 29.1% of the total.

$732in general payments, 2019–2025

Across 23 payments — averaging $31.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$213
  • AbbVie$165
  • Lilly USA, LLC$138
  • Sun Pharmaceutical Industries Inc.$41
  • Mimedx Group, Inc.$35
  • Regeneron Healthcare Solutions, Inc.$26
  • plus $114 from 6 others

What the payments were for

  • Food & beverage$732100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$732 in reported general payments places this provider in the 75th percentile of 29 mohs-micrographic surgery providers in Minnesota.

See all mohs-micrographic surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$111,343
Medicare patients
96
Services billed
529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate16$753
Cefadroxil63$412
Triamcinolone Acetonide24$268
Ketoconazole15$166
Tramadol Hcl13$14

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →